[{"NetIncomeLoss_1_Q1_USD":23465000.0,"MarketableSecuritiesCurrent_0_Q1_USD":320578000.0,"SharesPaidForTaxWithholdingForShareBasedCompensation_1_Q1_shares":800000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q1_USD":6200000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":17999000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":249000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-3284000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":22520000.0,"AssetsCurrent_0_Q1_USD":409624000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":12850000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":29509000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":1268000.0,"LossContingencyAccrualAtCarryingValue_0_Q1_USD":0.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":10083000.0,"LossContingencyAccrualProvision_1_Q1_USD":0.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":432952000.0,"Assets_0_Q1_USD":552398000.0,"UnrecognizedTaxBenefitsPeriodIncreaseDecrease_1_Q1_USD":200000.0,"ShareBasedCompensation_1_Q1_USD":10101000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":2020000.0,"TreasuryStockCommonValue_0_Q1_USD":131855000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q1_USD":41000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-192000.0,"Liabilities_0_Q1_USD":41596000.0,"EarningsPerShareBasic_1_Q1_USD":0.2,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":129668000.0,"AccountsReceivableNetCurrent_0_Q1_USD":22200000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-3552000.0,"CommonStockValue_0_Q1_USD":124000.0,"ProceedsFromIssuanceOrSaleOfEquity_1_Q1_USD":4038000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q1_USD":10142000.0,"TreasuryStockValueAcquiredCostMethod_1_Q1_USD":33540000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":254000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-45947000.0,"CostsAndExpenses_1_Q1_USD":59799000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":124230000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-866000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":23299000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-3493000.0,"OtherAssetsNoncurrent_0_Q1_USD":5030000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":52381000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":0.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":536363000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":-3217000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":29022000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":37025000.0,"InterestReceivableCurrent_0_Q1_USD":1700000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":127388000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":2107000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":16444000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":10142000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":26000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q1_USD":-166000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":25422000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":116818000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":81834000.0,"LiabilitiesCurrent_0_Q1_USD":40601000.0,"AccountsPayableCurrent_0_Q1_USD":6969000.0,"NonoperatingIncomeExpense_1_Q1_USD":275000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":52381000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":9517000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":314000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":1800000.0,"InventoryNoncurrent_0_Q1_USD":15384000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q1_USD":61000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1481000.0,"EarningsPerShareDiluted_1_Q1_USD":0.18,"AccruedIncomeTaxesNoncurrent_0_Q1_USD":995000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-3998000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":105921000.0,"IncreaseDecreaseInAccruedTaxesPayable_1_Q1_USD":597000.0,"TreasuryStockSharesAcquired_1_Q1_shares":7900000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2850000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":79437000.0,"OperatingIncomeLoss_1_Q1_USD":19638000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":19913000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":33541000.0,"InventoryNet_0_Q1_USD":4948000.0,"PreferredStockValue_0_Q1_USD":0.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-5360000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":552398000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":3992000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":3588000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2067000.0,"ProfitLoss_1_Q1_USD":23465000.0,"StockholdersEquity_0_Q1_USD":510802000.0,"AccruedMarketingCostsCurrent_0_Q1_USD":610000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":126000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":26800000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-23809000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":585000.0,"Ticker":"CORT","CIK":"1088856","name":"CORCEPT THERAPEUTICS INC","OfficialName":"Corcept Therapeutics Incorporated Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2458327425.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]